Study Identifies 24 Adverse Events Associated with Secukinumab Treatment - MD Magazine

Despite most adverse events of special interest being deemed mild to moderately severe in nature, these types of events have been increasingly reported in real-world practice.

A new systematic review of secukinumab-induced adverse events of special interest (AESI) in patients with moderate to severe plaque psoriasis found that the most common AESI were inflammatory bowel d… [+2742 chars]

full article...